DIAGNOSIS

The diagnosis of pleural mesothelioma is often difficult because the symptoms are similar to many other conditions. The diagnosis begins with a review of medical history, followed by a complete physical examination including a chest radiograph and pulmonary function studies. CT and MRI can be useful in determining the extent and location of the lesion.

To confirm the diagnosis requires a biopsy can be done by thoracoscopy or, if this is not possible through conventional surgery. Once the existence diagnosis, determine that the stage of the disease in order to proceed with the best treatment for mesothelioma.

The purpose of the trials is to involve patients in finding new and better treatments for mesothelioma diseases. Several clinical studies have different objectives, which may include the study of new drugs compare different ways of treating a disease or the study of various techniques for preventing cancer. Clinical trials are divided into three phases. Here, we show brief summaries of the goal of each phase of the trial.

The Phase I clinical studies are the first phase of clinical trial system. At this stage, the drugs have only been tested in the laboratory, but have had an effect on the destruction of cancer cells. These trials enroll only a limited number of participants and only made in limited centers specializing in the study of cancer. The objective of Phase I clinical studies is to find the maximum tolerated dose of the drug that causes no significant side effects, knowing the most common side effects if the drug continues to exhibit anticancer activity when administered to humans. If it is demonstrated that the drug has an effect on cancer using a safe dose, then the drug is examined in phase II clinical studies.

The Phase II clinical studies continue to study the safety of drugs or procedures, but also begin to study more closely its efficacy in specific types of cancer. These trials enroll a larger number of participants and can be performed in more centers. These trials may be “randomized”, which means that a computer, not a doctor, select different groups of participants.

The Phase III clinical studies comparing new drugs or procedures with current standard treatment. In these clinical trials enroll large numbers of participants from many areas and receive the new treatment or usual treatment. One of the primary objectives of Phase III clinical studies is to determine whether drugs have reduced or slowed the cancer, how long patients remain stable without progression of disease and as drug treatment affects quality of life for patients.

If you are interested in (a) to participate in a clinical study on mesothelioma, your doctor should be able to offer information on eligibility and availability in your area.

The first definitive relationship between mesothelioma and asbestos was made in the 1960s. At that time, asbestos was widely used in the manufacture of insulating materials such as insulation boards and building materials, including cement.

When asbestos is damaged or disturbed, it releases small fibers, almost invisible to the naked eye, which, when air can take a deep breath, and can not be breathed or coughed out. After the fibers are in the lungs, the body’s defense mechanisms try to break them down and remove them, which causes inflammation in lung tissue.

Asbestos fibers can penetrate the lung tissue to settle in the pleura (the lining around the lungs). For years, they can cause asbestosis, mesothelioma or other lung disease to develop. Asbestos fibers also can be swallowed, and some of the fibers to be filed in the digestive system. They will then move to the membrane lining the abdomen (peritoneum), where they cause inflammation.

They most likely have been exposed to asbestos will include: individual construction workers, boilermakers, construction workers, demolition workers, electrical, plumbers, shipbuilders and other family members of those who worked with asbestos and unknowingly brought home asbestos dust on their clothes , will also be at risk and also has been known for mesothelioma developed.

There are three types of asbestos and are: blue, brown and white. Type of brown and blue asbestos are most commonly associated with mesothelioma, and now very rarely used. However, although initially, the white asbestos is not considered dangerous, recent studies have shown that it is also dangerous.

Although in 1999 the import and use of all banned asbestos, and because mesothelioma develops so slowly, it is estimated that in 2015, about 3000 people would have was diagnosed with mesothelioma every year. After this time, the number of people who develop mesothelioma will begin to fall every year.

Mesothelioma does not usually develop for years after the initial exposure to asbestos. While it can take something 10-60 years, averaging around 30 to 40 years after exposure to asbestos.

Occasionally, mesothelioma will be diagnosed in people who have never had a history of asbestos exposure. Other causes of this disease is to date not fully understood, but in rare cases mesothelioma has been linked with radiation exposure.

Research has found evidence that smoking increases the risk of someone developing mesothelioma. It is understood that exposure to other building materials, for example fiberglass will also not increase the risk. Mesothelioma is not a contagious disease and therefore can not be passed on to others. Family members at risk only when in contact with asbestos particles.

An asbestos fiber is 400 to 2 000 times smaller than a human hair, allowing it to penetrate to the alveoli: gas exchange take place between air and blood circulation.

Trapped, these fibers can cause inflammation or non-cancerous chromosomal abnormalities, the starting point for benign disease or cancer:

Asbestosis

Asbestos pleural disease asbestosis cancer mésothéliomesLes asbestos fibers enter the lungs and cause inflammation, which is transformed into fibrosis (thickening of lung tissue). It generally takes about ten years between inhalation and onset of the disease. Shortness of breath, dry cough, tightness are the first symptoms can progress to respiratory failure, which can be fatal.

The diagnosis is based on radiography, tomography and functional exploration and detection of asbestos bodies in bronchial secretions.

There is no effective treatment for this disease in decline since the decrease rates of asbestos exposure.

Benign pleural

These lesions of the pleura are not the beginnings of cancer of the lung or pleura (mesothelioma). There are different types of benign pleural pleurisy benign (collection of fluid), pleural fibrosis (sclerosis secondary to pleurisy can sometimes lead to calcification), atelectasis, wound (benign mass developing in the contact of the pleura).

These injuries can sometimes cause a decrease in breathing capacity or pain.

Mesothelioma

Mesothelioma reaches the membrane of the pleura or, less commonly the peritoneum (the protective membrane of the intestines in the abdominal cavity) or the pericardium (membrane that surrounds the heart). The pleural cancer is almost exclusively related to exposure to asbestos. Tobacco is no way implicated in mesothelioma. This disease can develop thirty to forty years after exposure to asbestos.

Chemotherapy is used to treat cancer since early 1940, but that scientific progress and understanding of the nature of the disease led to further research and development of new targeted chemotherapy. Chemotherapy more effective when cancer cells are relatively young are not united in a solid tumor, it is extremely difficult to chemotherapy drugs impregnate a solid tumor mass.
Mesothelioma Chemotherapy

The term chemotherapy can be used for all drugs used to treat the disease to describe, but the word is often used to refer to drugs used in cancer treatment. The term refers to treatment of disease with chemicals that kill cells.

Typically, chemotherapy drugs work by targeting specific processes in cells that are in the process of dividing and growing fast, which prevents cell division, killing cancer cells. Unfortunately, these drugs are not very precise, and in addition to killing cancer cells, chemotherapy drugs also kill healthy cells, including those involved in its growth.

In terms of treatment options for mesothelioma chemotherapy are available. Most chemotherapeutic drugs have specific side effects such as nausea, vomiting, loss of appetite, hair loss, and increased susceptibility to infections. No known symptoms during treatment with chemotherapy drugs must be reported to the doctor.

With mesothelioma, many use chemotherapy as a treatment. Understanding the various options available and chemotherapy often helps patients and their families, make the best decision for their personal situation. We offer a complete package detailing options and chemotherapy treatment and information on side effects of treatment, patients and families with the most recent information available. Click here to set this night.

Evaluate the options of chemotherapy

To decide which option is the best chemotherapy treatment for mesothelioma depends on several specific factors, including the type of mesothelioma, the stage of disease, and other treatments are administered. Factors such as general physical health and age are taken into account in detail a plan of chemotherapy.

Currently more than 100 chemotherapy drugs on the market, but only a handful are considered suitable for the control of mesothelioma. In most cases, doctors treating patients with mesothelioma recommend a combination therapy – the use in tandem of two different drugs chemotherapy. These combinations have proved most effective in the fight against mesothelioma. .

All treatment options will be discussed in depth with the cancer patient’s physician before a decision is taken. Patients need a full disclosure of medical history, including details on prescriptions and over-the-counter medications for the treatment to be administered to ensure that the chemotherapy agent most appropriate.

Currently the most common chemotherapy drugs for mesothelioma ALIMTA (FDA only licensed drug specifically developed for the treatment of mesothelioma), cisplatin, carboplatin, Onconase, Gemcitabine and Navelbine. Drugs are usually administered traditionally (by IV or pill form), or can be used in a newer method, called heated chemotherapy

Mesothelioma is a cancer of pleura (the lining of the lungs), around the inner wall of the heart or the lining of the abdominal cavity. Although cancer mesothelioma is rare, most people die after one or two years of diagnosis.

The majority of mesothelioma cases are traced back to exposure to asbestos – and no other cause of this cancer has never been found. Exposure to asbestos is happening primarily through jobs that were occupied by people working with asbestos, and military service. Until 20 years ago, many products and materials that were used in the manufacture and construction used asbestos until it is found that exposure to the product caused mesothelioma and other problems health.

During the Second World War, when naval shipyards have been producing many ships for the war effort, asbestos was widely used and demand. Asbestos was also used for the construction of all types of buildings, as well as manufacturing and automotive. Until recently, processes and products have been used asbestos unregulated, but the risks of asbestos exposure were well known yet, but companies that use the product continued to use asbestos-free in their practices.

The one truth is unfortunate is that many companies have made use of asbestos has provided little in the way of education or the protection of exposure to asbestos workers. This does however leave companies on the hook for compensation for victims of mesothelioma.

Unfortunately, this is not only the workers who contract mesothelioma, it is also their families, spouses and children of workers who worked with asbestos are also at risk of contact with this deadly cancer. Asbestos is a virtually indestructible, very fine fibers that can be easily inhaled and is then deposited in the lining of the lungs especially, which causes inflammation and mesothelioma. These fibers are easily attached to the back skin, hair, shoes or clothing, then dislodged at home, exposing more people to asbestos, and thusly, mesothelioma.

If someone you love or you have mesothelioma, you need to contact a mesothelioma lawyer to see if you have a case for a lawsuit mesothelioma. The greatest difficulty with exposure to asbestos and mesothelioma symptoms early is the long delay between exposure and diagnosis. Mesothelioma does not usually begin to show symptoms until about 20 years after exposure to asbestos. This makes it very difficult to diagnose cancer and monitoring of exposure to asbestos, the cause or companies that are responsible.

Symptoms of mesothelioma include fluid in the chest, chest pain, difficulty breathing, and coughing. Due to the nature of these symptoms and the fact they are so similar to other medical problems, they are easily confused with other conditions, which may delay diagnosis of mesothelioma cancer. Unfortunately, when people are diagnosed with mesothelioma, it is too late – most people spend one or two years after diagnosis and conventional cancer treatments like radiation and chemotherapy have little effect on disease.

Most cases of mesothelioma can blame the companies and supervisors for whom they have worked in the past with asbestos. Most people and businesses knew of the dangers of working with asbestos and failed to take all precautions for the handling of materials. This cancer is devastating for those who have and their families, physically, emotionally and financially.

A Texas mesothelioma lawyer can help you build a case for you or a loved one has mesothelioma. A Texas mesothelioma attorney is the only one who is able to track companies that are responsible for exposure to asbestos. A good mesothelioma lawyer in Texas can help you to a mesothelioma trial financial compensation for you and your family.

A mesothelioma lawyer can link your cancer with exposure to asbestos that you had when you worked before, and fight for your rights and compensation for the mesothelioma cancer that you have incurred as a result of exposure. While compensation will not replace a life lost to cancer mesothelioma, it can help cover lost wages, pain and suffering, funeral expenses and medical costs that were caused by cancer.

It is possible to observe the occurrence of lesions in groups exposed to low concentrations of asbestos fibers into the air inhaled (environmental exposures in locations containing asbestos exposure and urban).

Two types of studies have been proposed to try to answer the questions on environmental risk, one based on the epidemiology of mesothelioma in women, the other on comparisons between exposed and unexposed.

Occupations involving exposure to asbestos risk being primarily male, it was tempting to analyze the development of mesothelioma in women by attributing these tumors to environmental contamination.

The weight of professional mesothelioma is such that despite the low exposure of women to the risk it introduces a confounding factor that does not allow a comprehensive interpretation of the incidence of mesothelioma in women.

On this point, the report’s conclusion is that the Inserm:
“The analysis of the evolution of the incidence of mesothelioma among women in industrialized countries does not in any way to identify a possible environmental component passive intramural and urban.

It appears, as for men, the professional component and para-professional is such a burden that any additional cases attributable to passive exposure intramural and urban areas is completely indistinguishable in the development of mesothelioma. This does not mean that such an addition does not exist “.

The second method is to compare groups of people exposed and not exposed to risks of environmental contamination, such as working in premises containing asbestos for insulation or protection against fire.

The very limited number of studies using a methodology acceptable (presence of a control group, removal with a thorough study of contamination of the professional type linked to direct intervention on asbestos) does not permit the use of data available in the literature to confirm the absence of risk or its existence.

The report from Inserm analyzes this data and concludes that:
“We must consider it does at present any direct solid epidemiological evidence to make judgments about the health effects associated with environmental exposures passive intramural and locations.

A special situation has been used to try to assess a form of environmental risk, that of people living near an industrial exploitation of asbestos (careers or industries using asbestos, for example, for the production of fibro -cements).

The study appears to be the best documented is that of the female population of the two main mining towns of Canada where asbestos is mined: Asbestos and Thetford.

The reconstruction on the level of risk to which populations of these towns have been exposed (mean concentration and duration) indicates higher values for Thetford for Asbestos, mainly due to the development of measures of environmental protection on the latter Site that divided by a factor greater than 10 the rate of fiber from the beginning of the decade fifty.

The selected values are 40 000 f / lx years for Asbestos and 87 000 Thetford, which should be added exhibitions paraprofessional and servants who combine with environmental exposure.

The available evidence (that a study is not fully completed) indicate no increased risk for cancers of the lung (but women in these regions would be slightly less smoky than the rest of Quebec) and over-risk for mesothelioma.

The six mesotheliomas have been observed in Thetford where the rock used contains tremolite, no cases have been observed in Asbestos, where chrysotile is not contaminated with amphiboles.

According to the Centers for Disease Control and Prevention (CDC), malignant mesothelioma death in the United States from 1999 to 2005 was 18,068 people. The death has increased from 2,482 deaths in 1999 to 2704 in 2005, an increase of 222 deaths.

The men are diagnosed with mesothelioma more often than women and men is 80.8 per cent of mesothelioma deaths during this period (a total of 14,591). The whites are 95.1 percent of deaths from mesothelioma, a total of 17,180.

Effect of age on mortality, aged 75 and over, the majority of patients died of mesothelioma (8858 total deaths). Deaths in patients aged 44 years or less was 311, or 1.7 percent.

During the period covered by the study of the CDC, the state was the death rate from mesothelioma more than the national rate of 13.8 deaths per million people per year. In six countries, the mesothelioma mortality rate was over 20 per million population per year.

The death rate from mesothelioma is highest in Maine, at 27.5 percent (173 total), followed by Wyoming (22.2 per cent, 50 dead), West Virginia (21 percent of 182 deaths ), Pennsylvania (20.8 percent, death 1210), New Jersey (20.2 percent, 814 deaths) and Washington (20.1 percent, 558 deaths).

Cancer treatment currently provided (in the early twenty-first century) science is based on three pillars: surgery, chemotherapy and radiotherapy. There is a fourth pillar called biological therapy include hormone therapy, immunotherapy, and new non-cytotoxic therapeutic targets.

Cancer treatment is multidisciplinary where cooperation between different professionals involved (surgeons, medical oncologists and radiation oncologists), is of utmost importance for planning the same, not forgetting the patient’s informed consent. At all times, emotional support is essential.
The treatment plan must be defined if the intent is curative or palliative.

Treatment response may be:

* Complete: If there was the disappearance of all signs and symptoms of the disease.
* Partial: If there is a greater than 50% decrease in the sum of the products of perpendicular diameters of all measurable lesions.
* Objective: The complete or partial response.
* Progression: If there exists any new lesion or an increase greater than 25% of the sum of the products of perpendicular diameters of all measurable lesions.
* Stable: If there is tumor growth or reduction which satisfies none of the above criteria.

When it is not possible to measure the lesions, tumor markers are useful to assess response to treatment.